Health News
Topics also related to Health:
How secure are labs handling world's deadliest pathogens?
NEW YORK/CHICAGO - To reach his office in Galveston National Laboratory, where scientists study deadly pathogens such as the Ebola and Marburg viruses, director James Le Duc swipes his key card at the building's single entrance, which is guarded 24/7 by Texas state police.
In prostate cancer, other death risks may be higher
NEW YORK (Reuters Health) - Some men with prostate cancer may have increased risks of dying from causes other than the cancer itself, a new study finds.
Analysis: Drugmakers relegate Europe as crisis saps returns
LONDON - Europe's debt crisis is not only making its citizens poorer, it is also reducing their access to cutting-edge medicines.
Bishops plan big birth-control battle expansion
- Catholic bishops, energized by a battle over contraception funding, are planning an aggressive campaign to rally Americans against a long list of government measures which they say intrude on religious liberty.
Counterfeits of cancer drug Avastin found in U.S.
- Counterfeit versions of Roche's multi-billion cancer drug Avastin have been distributed in the United States, the Swiss drugmaker and its U.S. biotech unit Genentech said on Tuesday.
Decision time for researchers of deadly bird flu
LONDON/GENEVA - When 22 bird flu experts meet at the World Health Organization this week, they will be tasked with deciding just how far scientists should go in creating lethal mutant viruses in the name of research.
Vitamin B and fish oil fail to prevent cancer
NEW YORK (Reuters Health) - Among more than 2,500 people in France with a history of heart disease, taking B vitamins or omega-3 fatty acid supplements did not reduce the risk of developing cancer in a new study. In fact, for a small group of women, fish oil was linked to higher cancer risk.
Antibiotics no help against most sinus infections: study
- Antibiotics don't help fight most sinus infections, although doctors routinely prescribe them for that purpose, according to a U.S. study.
BioCryst hep C drug shows promise, shares jump
- BioCryst Pharmaceuticals Inc said its experimental hepatitis C drug showed promise in preclinical studies, sending its shares up as much as 16 percent to their highest in more than seven months.
Debate recap: Bird Flu Research
Dangerous information on a deadly virus
A call to censor scientific research on the deadly bird flu virus has global health officials debating whether such studies are worth the risk. Read our recap of a Harvard School of Public Health discussion on this subject, presented in collaboration with Reuters. Learn More
Love is in the air for Indians as V-Day police keep away
Conservative right-wing activists in India have their own version of how Valentine's Day should be celebrated, if at all. For them, couples found kissing, dancing and snuggling need to be humiliated publicly or beaten, especially if this behaviour is exhibited on the “day of lust and shame”.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
